Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release Tablets

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.
Products
  • Metoprolol Succinate Extended-Release Tablets
Where it was sold

Nationwide in the USA.

Nationwide

Units affected
27,648 100-count Bottles; 5,376 500-count Bottles
About this recall
Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,